long intergenic non-protein coding RNA 1128Genealiases: []
Q-omics provides the consensus-scored LINC01128 profile across patient tissues and cancer cell-line models. LINC01128 expression is associated with patient survival in 28 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, LINC01128 is differentially expressed in 12, with the highest sampling consensus in KICH. Additionally, LINC01128 RNA expression shows 20,005 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight MESO, KICH, and ACC as cancer lineages where LINC01128 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01128 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01128 survival associations across molecular data types. LINC01128 RNA expression shows survival associations in the most cancer types (28). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01128 RNA expression–survival associations across cancer types. High LINC01128 expression shows unfavorable associations in MESO, COAD, HNSC, KICH and LUSC, but favorable associations in LUAD. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for LINC01128 RNA expression.
This table summarizes LINC01128 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01128. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01128 shows lower tumor expression in KICH, BRCA, LUSC and BLCA and higher tumor expression in HNSC and PRAD. The KICH box plot shows higher LINC01128 RNA expression in normal versus tumor tissue (log2 FC = −1.077, t-test p < 0.001).
This table shows molecular features associated with LINC01128 in patient tissues and cancer cell lines. In patient samples, LINC01128 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
